Non-small Cell Lung Cancer
Conditions
Interventions
Case series:the third cycle chemotherapy and the 7th week targeted therapy
Sponsors
Shanghai Chest Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patient with NSCLC confirmed by pathological biopsy; stage III-IV; plan to palliative chemotherapy (such as neoadjuvant chemotherapy, convention and targeted therapy) due to unable to surgery; not radiation therapy or chemotherapy for 6 months before enrollment; the predictive survival time more than half year;
Exclusion criteria
Exclusion criteria: ?with diabetes and chest radiotherapy chronic disease; brain metastases patients; with secondary primary maligmant cancer in 5 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dertermine Glucose metabolism discrepancy of different genotype NSCLC;Study and Quantify Different genotype NSCLC metabolic response after treatment;Dertermine Time points of predictive specific genotype NSCLC glucose metabolic response; | — |
Countries
China
Contacts
Public ContactWenhui Xie
Shanghai Chest Hospital
Outcome results
None listed